ADGC Publications

Found 25 results
Filters: Author is Wang, Li-San  [Clear All Filters]
2023
Tejeda M, Farrell J, Zhu C, Wetzler L, Lunetta KL, Bush WS, Martin ER, San Wang L-, Schellenberg GD, Pericak-Vance MA et al..  2023.  DNA from multiple viral species is associated with Alzheimer's disease risk.. Alzheimers Dement.
Ray NR, Ayodele T, Jean-Francois M, Baez P, Fernandez V, Bradley J, Crane PK, Dalgard CL, Kuzma A, Nicaretta H et al..  2023.  The Early-Onset Alzheimer's Disease Whole-Genome Sequencing Project: Study design and methodology.. Alzheimers Dement.
Kang M, Ang TFang Alvin, Devine SA, Sherva R, Mukherjee S, Trittschuh EH, Gibbons LE, Scollard P, Lee M, Choi S-E et al..  2023.  A genome-wide search for pleiotropy in more than 100,000 harmonized longitudinal cognitive domain scores.. Mol Neurodegener. 18(1):40.
Li D, Farrell JJ, Mez J, Martin ER, Bush WS, Ruiz A, Boada M, de Rojas I, Mayeux R, Haines JL et al..  2023.  Novel loci for Alzheimer's disease identified by a genome-wide association study in Ashkenazi Jews.. Alzheimers Dement.
2022
Kuksa PP, Liu C-L, Fu W, Qu L, Zhao Y, Katanic Z, Clark K, Kuzma AB, Ho P-C, Tzeng K-T et al..  2022.  Alzheimer's Disease Variant Portal: A Catalog of Genetic Findings for Alzheimer's Disease.. J Alzheimers Dis. 86(1):461-477.
Holstege H, Hulsman M, Charbonnier C, Grenier-Boley B, Quenez O, Grozeva D, van Rooij JGJ, Sims R, Ahmad S, Amin N et al..  2022.  Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease.. Nat Genet. 54(12):1786-1794.
Chung J, Das A, Sun X, Sobreira DR, Leung YYee, Igartua C, Mozaffari S, Chou Y-F, Thiagalingam S, Mez J et al..  2022.  Genome-wide association and multi-omics studies identify MGMT as a novel risk gene for Alzheimer's disease among women.. Alzheimers Dement.
Vardarajan BN, Reyes-Dumeyer D, Piriz AL, Lantigua RA, Medrano M, Rivera D, Jimenez-Velazquez IZ, Martin E, Pericak-Vance MA, Bush W et al..  2022.  Progranulin mutations in clinical and neuropathological Alzheimer's disease.. Alzheimers Dement. 18(12):2458-2467.
Jun GR, You Y, Zhu C, Meng G, Chung J, Panitch R, Hu J, Xia W, Bennett DA, Foroud TM et al..  2022.  Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE ɛ2 for Alzheimer's disease.. Alzheimers Dement. 18(11):2042-2054.
Wang H, San Wang L-, Schellenberg G, Lee W-P.  2022.  The role of structural variations in Alzheimer's disease and other neurodegenerative diseases.. Front Aging Neurosci. 14:1073905.
2021
Zhang X, Farrell JJ, Tong T, Hu J, Zhu C, San Wang L-, Mayeux R, Haines JL, Pericak-Vance MA, Schellenberg GD et al..  2021.  Association of mitochondrial variants and haplogroups identified by whole exome sequencing with Alzheimer's disease.. Alzheimers Dement.
2020
Reiman EM, Arboleda-Velasquez JF, Quiroz YT, Huentelman MJ, Beach TG, Caselli RJ, Chen Y, Su Y, Myers AJ, Hardy J et al..  2020.  Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study.. Nat Commun. 11(1):667.
Dumitrescu L, Mahoney ER, Mukherjee S, Lee ML, Bush WS, Engelman CD, Lu Q, Fardo DW, Trittschuh EH, Mez J et al..  2020.  Genetic variants and functional pathways associated with resilience to Alzheimer's disease.. Brain. 143(8):2561-2575.
2019
Wheeler JM, McMillan P, Strovas TJ, Liachko NF, Amlie-Wolf A, Kow RL, Klein RL, Szot P, Robinson L, Guthrie C et al..  2019.  Activity of the poly(A) binding protein MSUT2 determines susceptibility to pathological tau in the mammalian brain.. Sci Transl Med. 11(523)
Bis JC, Jian X, Kunkle BW, Chen Y, Hamilton-Nelson KL, Bush WS, Salerno WJ, Lancour D, Ma Y, Renton AE et al..  2019.  Correction: Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation.. Mol Psychiatry.
Amlie-Wolf A, Tang M, Way J, Dombroski B, Jiang M, Vrettos N, Chou Y-F, Zhao Y, Kuzma A, Mlynarski EE et al..  2019.  Inferring the Molecular Mechanisms of Noncoding Alzheimer's Disease-Associated Genetic Variants.. J Alzheimers Dis. 72(1):301-318.
Leung YYee, Valladares O, Chou Y-F, Lin H-J, Kuzma AB, Cantwell L, Qu L, Gangadharan P, Salerno WJ, Schellenberg GD et al..  2019.  VCPA: genomic variant calling pipeline and data management tool for Alzheimer's Disease Sequencing Project.. Bioinformatics. 35(11):1985.
2018
Sanchez-Contreras MY, Kouri N, Cook CN, Serie DJ, Heckman MG, Finch NCA, Caselli RJ, Uitti RJ, Wszolek ZK, Graff-Radford N et al..  2018.  Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci.. Mol Neurodegener. 13(1):37.
Bis JC, Jian X, Kunkle BW, Chen Y, Hamilton-Nelson KL, Bush WS, Salerno WJ, Lancour D, Ma Y, Renton AE et al..  2018.  Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation.. Mol Psychiatry.
2016
Leung YYee, Kuksa PP, Amlie-Wolf A, Valladares O, Ungar LH, Kannan S, Gregory BD, San Wang L-.  2016.  DASHR: database of small human noncoding RNAs.. Nucleic Acids Res. 44(D1):D216-22.
2015
Kouri N, Ross OA, Dombroski B, Younkin CS, Serie DJ, Soto-Ortolaza A, Baker M, Finch NCole A, Yoon H, Kim J et al..  2015.  Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy.. Nat Commun. 6:7247.
2013
Ryvkin P, Leung YYee, Silverman IM, Childress M, Valladares O, Dragomir I, Gregory BD, San Wang L-.  2013.  HAMR: high-throughput annotation of modified ribonucleotides.. RNA. 19(12):1684-92.
2011
Höglinger GU, Melhem NM, Dickson DW, Sleiman PMA, San Wang L-, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE et al..  2011.  Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.. Nat Genet. 43(7):699-705.
2010
Van Deerlin VM, Sleiman PMA, Martinez-Lage M, Chen-Plotkin A, San Wang L-, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Grossman M et al..  2010.  Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions.. Nat Genet. 42(3):234-9.
Han M-R, Schellenberg GD, San Wang L-.  2010.  Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.. BMC Neurol. 10:90.